JP2024514691A - 抗原結合タンパク質の遺伝子操作 - Google Patents

抗原結合タンパク質の遺伝子操作 Download PDF

Info

Publication number
JP2024514691A
JP2024514691A JP2023564230A JP2023564230A JP2024514691A JP 2024514691 A JP2024514691 A JP 2024514691A JP 2023564230 A JP2023564230 A JP 2023564230A JP 2023564230 A JP2023564230 A JP 2023564230A JP 2024514691 A JP2024514691 A JP 2024514691A
Authority
JP
Japan
Prior art keywords
sequence
chain
sequences
strand
heavy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2023564230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024514691A5 (https=
Inventor
リーム，ジヌ
ギャルソン，ジェイコブ
Original Assignee
アルケマブ セラピューティクス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルケマブ セラピューティクス リミテッド filed Critical アルケマブ セラピューティクス リミテッド
Publication of JP2024514691A publication Critical patent/JP2024514691A/ja
Publication of JP2024514691A5 publication Critical patent/JP2024514691A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/30—Drug targeting using structural data; Docking or binding prediction
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/044—Recurrent networks, e.g. Hopfield networks
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/045—Combinations of networks
    • G06N3/0455—Auto-encoder networks; Encoder-decoder networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G16B35/10—Design of libraries
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics

Landscapes

  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Data Mining & Analysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Molecular Biology (AREA)
  • Library & Information Science (AREA)
  • Databases & Information Systems (AREA)
  • Bioethics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Computing Systems (AREA)
  • General Physics & Mathematics (AREA)
  • Computational Linguistics (AREA)
  • Mathematical Physics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2023564230A 2021-04-22 2022-04-14 抗原結合タンパク質の遺伝子操作 Withdrawn JP2024514691A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2105776.5A GB202105776D0 (en) 2021-04-22 2021-04-22 Engineering of antigen-binding proteins
GB2105776.5 2021-04-22
PCT/EP2022/060073 WO2022223451A1 (en) 2021-04-22 2022-04-14 Engineering of antigen-binding proteins

Publications (2)

Publication Number Publication Date
JP2024514691A true JP2024514691A (ja) 2024-04-02
JP2024514691A5 JP2024514691A5 (https=) 2025-04-18

Family

ID=76193388

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023564230A Withdrawn JP2024514691A (ja) 2021-04-22 2022-04-14 抗原結合タンパク質の遺伝子操作

Country Status (10)

Country Link
US (1) US20240203523A1 (https=)
EP (1) EP4327328A1 (https=)
JP (1) JP2024514691A (https=)
KR (1) KR20240011144A (https=)
CN (1) CN117337470A (https=)
AU (1) AU2022260043A1 (https=)
CA (1) CA3215778A1 (https=)
GB (1) GB202105776D0 (https=)
IL (1) IL307832A (https=)
WO (1) WO2022223451A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113392929B (zh) * 2021-07-01 2024-05-14 中国科学院深圳先进技术研究院 一种基于词嵌入与自编码器融合的生物序列特征提取方法
IL321771A (en) 2023-01-09 2025-08-01 Lilly Co Eli Anti-unc5c antibodies
EP4688852A2 (en) 2023-04-03 2026-02-11 Alchemab Therapeutics Ltd. Anti-cd33 antibodies
WO2025022002A1 (en) 2023-07-26 2025-01-30 Alchemab Therapeutics Ltd Analysis of antigen-binding proteins
US20250079011A1 (en) * 2023-09-01 2025-03-06 Siemens Healthcare Diagnostics Inc. Clinical decision support using transformer-based networks by imputing biomarkers
WO2025125898A1 (en) 2023-12-15 2025-06-19 Alchemab Therapeutics Ltd Anti-unc5c antibodies and uses thereof
US12367329B1 (en) * 2024-06-06 2025-07-22 EvolutionaryScale, PBC Protein binder search

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7648099B2 (ja) * 2019-05-19 2025-03-18 ジャスト－エヴォテック バイオロジクス，インコーポレイテッド 機械学習法によるタンパク質配列の生成

Also Published As

Publication number Publication date
CN117337470A (zh) 2024-01-02
CA3215778A1 (en) 2022-10-27
WO2022223451A1 (en) 2022-10-27
US20240203523A1 (en) 2024-06-20
EP4327328A1 (en) 2024-02-28
GB202105776D0 (en) 2021-06-09
IL307832A (en) 2023-12-01
KR20240011144A (ko) 2024-01-25
AU2022260043A1 (en) 2023-11-16

Similar Documents

Publication Publication Date Title
US20240203523A1 (en) Engineering of antigen-binding proteins
Prihoda et al. BioPhi: A platform for antibody design, humanization, and humanness evaluation based on natural antibody repertoires and deep learning
Kim et al. Germinal centre-driven maturation of B cell response to mRNA vaccination
Mason et al. Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning
Shuai et al. Generative language modeling for antibody design
Mhanna et al. Adaptive immune receptor repertoire analysis
Imkeller et al. Assessing human B cell repertoire diversity and convergence
Friedensohn et al. Convergent selection in antibody repertoires is revealed by deep learning
Richardson et al. A computational method for immune repertoire mining that identifies novel binders from different clonotypes, demonstrated by identifying anti-pertussis toxoid antibodies
WO2025022002A1 (en) Analysis of antigen-binding proteins
JP2025500075A (ja) 免疫学的ペプチド配列を評価するためのシステムおよび方法
Xu et al. Advances in antibody discovery from human BCR repertoires
Yan et al. Deep immunoglobulin repertoire sequencing depicts a comprehensive atlas of spike-specific antibody lineages shared among COVID-19 convalescents
Cohen et al. NanoNet: Rapid end-to-end nanobody modeling by deep learning at sub angstrom resolution
JP2025536256A (ja) 抗原結合性タンパク質の工学操作
Campbell et al. Combining random mutagenesis, structure-guided design and next-generation sequencing to mitigate polyreactivity of an anti-IL-21R antibody
US20250125011A1 (en) Systems and methods for intelligent construction of antibody libraries
Kuroda et al. Optimizing the breadth of SARS-CoV-2-neutralizing antibodies in vivo and in silico
Zeglinski et al. alpseq: an open-source workflow to turbocharge nanobody discovery with high-throughput sequencing
Zhao et al. Quantitative characterization of the B cell receptor repertoires of human immunized with commercial rabies virus vaccine
Zou et al. Antibody humanization via protein language model and neighbor retrieval
Mitchell Advancing hybridoma sequencing, dissemination, and antibody validation with novel
Fujiwara et al. De novo design of therapeutic scFvs and multi-specific engagers from sequence alone
Raybould Structure-aware tools for the development of therapeutic antibodies from natural immunoglobulins
Reers et al. Back to basics: Immunoglobulin germline reference sequences enable investigations and reveal insights into bat-specific immunity

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250410

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250410

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20260326

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20260326